According to PANews, Quantum BioPharma Ltd., a publicly traded biopharmaceutical company listed on NASDAQ and CSE under the ticker QNTM, has announced the purchase of $1 million worth of Bitcoin and other cryptocurrencies. This decision, approved by the company's board of directors, is part of its strategic initiatives. The company plans to facilitate future financing and transactions using cryptocurrencies. All acquired digital assets are entrusted to a fully compliant custodian, ensuring adherence to financial and audit regulations for secure and legal processes. Quantum BioPharma will continue to monitor market conditions and may adjust its cryptocurrency holdings as deemed appropriate.